The Cooper (LTS:0I3I) Additional Paid-In Capital : $1,867 Mil(As of Apr. 2024)

View and export this data going back to 2018. Start your Free Trial

What is The Cooper Additional Paid-In Capital?

The Cooper's quarterly additional paid-in capital increased from Oct. 2023 ($1,833 Mil) to Jan. 2024 ($1,847 Mil) and increased from Jan. 2024 ($1,847 Mil) to Apr. 2024 ($1,867 Mil).

The Cooper's annual additional paid-in capital increased from Oct. 2021 ($1,715 Mil) to Oct. 2022 ($1,766 Mil) and increased from Oct. 2022 ($1,766 Mil) to Oct. 2023 ($1,833 Mil).

The Cooper Additional Paid-In Capital Historical Data

The historical data trend for The Cooper's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Additional Paid-In Capital Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,615.00

1,646.80

1,715.20

1,765.50

1,833.40

The Cooper Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,800.70	1,817.40	1,833.40	1,847.40	1,866.70

The Cooper Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

The Cooper Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of The Cooper's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (LTS:0I3I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines